Nigrostriatal dopaminergic activities in dementia with lewy bodies in relation to neuroleptic sensitivity: Comparisons with Parkinson's disease

Margaret A. Piggott, Elaine K. Perry, Elizabeth F. Marshall, Ian G. McKeith, Mary Johnson, Heather L. Melrose, Jennifer A. Court, Stephen Lloyd, Andrew Fairbairn, Andrew Brown, Peter Thompson, Robert H. Perry

Research output: Contribution to journalArticle

55 Scopus citations

Abstract

Background: In dementia with Lewy bodies (DLB) mild extrapyramidal symptoms are associated with moderate reductions in substantia nigra neuron density and concentration of striatal dopamine. Many DLB patients treated with typical neuroleptics suffer severe adverse reactions, which result in decreased survival. Methods: In a series of DLB cases, with and without neuroleptic sensitivity, substantia nigra neuron densities, striatal dopamine and homovanillic acid concentrations, and autoradiographic [3H]mazindol and [3H]raclopride binding (to the dopamine transporter and D2 receptor, respectively) were analyzed and compared to control and idiopathic Parkinson's disease cases. Results: D2 receptors were up-regulated in neuroleptic-tolerant DLB and Parkinson's disease compared to DLB without neuroleptic exposure and controls. D2 receptors were not up-regulated in DLB cases with severe neuroleptic reactions. Dopamine uptake sites were reduced concomitantly with substantia nigra neuron density in Parkinson's disease compared to controls, but there was no significant correlation between substantia nigra neuron density and [3H]mazindol binding in DLB groups. There was no significant difference in substantia nigra neuron density, [3H]mazindol binding, and dopamine or homovanillic acid concentration between neuroleptic-tolerant and -sensitive groups. Conclusions: Failure to up-regulate D2 receptors in response to neuroleptic blockade or reduced dopaminergic innervation may be the critical factor responsible for neuroleptic sensitivity.

Original languageEnglish (US)
Pages (from-to)765-774
Number of pages10
JournalBiological psychiatry
Volume44
Issue number8
DOIs
StatePublished - Oct 15 1998

Keywords

  • D2 receptors
  • Dementia with Lewy bodies
  • Dopamine
  • Dopamine uptake sites
  • Neuroleptic sensitivity
  • Parkinson's disease
  • Substantia nigra

ASJC Scopus subject areas

  • Biological Psychiatry

Fingerprint Dive into the research topics of 'Nigrostriatal dopaminergic activities in dementia with lewy bodies in relation to neuroleptic sensitivity: Comparisons with Parkinson's disease'. Together they form a unique fingerprint.

  • Cite this

    Piggott, M. A., Perry, E. K., Marshall, E. F., McKeith, I. G., Johnson, M., Melrose, H. L., Court, J. A., Lloyd, S., Fairbairn, A., Brown, A., Thompson, P., & Perry, R. H. (1998). Nigrostriatal dopaminergic activities in dementia with lewy bodies in relation to neuroleptic sensitivity: Comparisons with Parkinson's disease. Biological psychiatry, 44(8), 765-774. https://doi.org/10.1016/S0006-3223(98)00127-9